Immune cell therapy for high-risk solid tumors in children and young adults
Part of Cancer, Immune system & allergy clinical trials.
This trial uses a patient's own tumor-fighting immune cells (TILs) to treat high-risk solid tumors outside the brain in children and young adults. It has two parts: first, a tumor sample is collected during surgery, and then the immune cells are grown in a lab and given back to the patient to attack the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 1 to 21 years for the first part (no upper age limit for the second part if enrolled in the first part)
- Have a high-risk solid tumor outside the brain, such as neuroblastoma, Ewing sarcoma, osteosarcoma, or other listed types
- Must be having surgery to remove or biopsy the tumor as part of standard care
- Weight at least 11 pounds (5 kg) when starting the treatment part
- Able to perform daily activities with minimal help (Karnofsky/Lansky score of 60% or higher)
- Good organ function: healthy blood counts, liver, kidneys, heart, and lungs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a type of immune cell treatment called TIL (tumor-infiltrating lymphocytes) in people with advanced solid cancers. It may help your immune system better recognize and attack tumors, especially if standard treatments have not worked.
This trial tests a treatment that uses your own immune cells, called TILs, to fight advanced solid tumors. The cells are taken from a biopsy of your tumor, multiplied in a lab, and then given back to you. It might help if you have tried other treatments without success, or if no standard treatment is available.
This trial tests an immunotherapy made from your own tumor-fighting immune cells (TIL). It may help people with advanced solid cancers that cannot be cured with surgery or radiation.
This trial tests a type of immunotherapy using special white blood cells (T-cells) that are trained to find and attack cancer cells. It is for children and young adults with high-risk solid tumors that have not gone away or have come back after standard treatment.
This trial tests a personalized therapy using your own immune cells (TILs) combined with immunotherapy to fight advanced breast cancer that has not responded to other treatments. It may help if you have a tumor that can be biopsied and you are generally healthy enough for the procedures.
This study tests a new treatment that uses your own immune cells, called TIL, to fight advanced solid tumors. It may be given alone or with another drug that helps the immune system attack cancer. The goal is to see if this treatment is safe and effective for people who have already tried other treatments.
Hear when a new Lymphocytes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.